Australia
· Delayed Price · Currency is AUD Percheron Therapeutics Statistics
Total Valuation
ASX:PER has a market cap or net worth of AUD 10.87 million. The enterprise value is -6.44 million.
| Market Cap | 10.87M |
| Enterprise Value | -6.44M |
Important Dates
The last earnings date was Tuesday, May 20, 2025.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:PER has 1.09 billion shares outstanding. The number of shares has increased by 41.43% in one year.
| Current Share Class | 1.09B |
| Shares Outstanding | 1.09B |
| Shares Change (YoY) | +41.43% |
| Shares Change (QoQ) | -10.24% |
| Owned by Insiders (%) | 15.03% |
| Owned by Institutions (%) | 0.92% |
| Float | 764.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.66 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.41 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.47 |
Financial Position
The company has a current ratio of 6.78, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.78 |
| Quick Ratio | 6.74 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -1,301.57 |
Financial Efficiency
Return on equity (ROE) is -99.00% and return on invested capital (ROIC) is -61.40%.
| Return on Equity (ROE) | -99.00% |
| Return on Assets (ROA) | -51.56% |
| Return on Invested Capital (ROIC) | -61.40% |
| Return on Capital Employed (ROCE) | -102.23% |
| Revenue Per Employee | 239,982 |
| Profits Per Employee | -1.96M |
| Employee Count | 8 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.11% in the last 52 weeks. The beta is 0.99, so ASX:PER's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -86.11% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 47.47 |
| Average Volume (20 Days) | 1,747,542 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:PER had revenue of AUD 1.92 million and -15.71 million in losses. Loss per share was -0.02.
| Revenue | 1.92M |
| Gross Profit | 1.80M |
| Operating Income | -15.63M |
| Pretax Income | -15.71M |
| Net Income | -15.71M |
| EBITDA | -15.63M |
| EBIT | -15.63M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 17.39 million in cash and 72,345 in debt, giving a net cash position of 17.32 million or 0.02 per share.
| Cash & Cash Equivalents | 17.39M |
| Total Debt | 72,345 |
| Net Cash | 17.32M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 15.29M |
| Book Value Per Share | 0.01 |
| Working Capital | 15.20M |
Cash Flow
In the last 12 months, operating cash flow was -13.84 million and capital expenditures -4,270, giving a free cash flow of -13.84 million.
| Operating Cash Flow | -13.84M |
| Capital Expenditures | -4,270 |
| Free Cash Flow | -13.84M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 93.99% |
| Operating Margin | -814.29% |
| Pretax Margin | -818.38% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:PER does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.43% |
| Shareholder Yield | n/a |
| Earnings Yield | -144.48% |
| FCF Yield | -127.29% |
Stock Splits
The last stock split was on November 6, 2013. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 6, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
ASX:PER has an Altman Z-Score of 5.93.
| Altman Z-Score | 5.93 |
| Piotroski F-Score | n/a |